NCT07725796
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07725796
Title A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
East Valley Urology Center of Arizona Queen Creek Arizona 85140 United States Details
Michael G Oefelein Clinical Trials Bakersfield California 93301 United States Details
Urology Center of Southern California Murrieta California 92563 United States Details
Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Ichan School of Medicine at Mount Sinai New York New York 10029 United States Details
SUNY Upstate Medical University Syracuse New York 13210 United States Details
University of Pennsylvania-Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 United States Details
START Carolinas Myrtle Beach South Carolina 29572 United States Details
UPNT Research Institute Arlington Texas 76017 United States Details
Urology Austin Austin Texas 78759 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field